Accumulation of garenoxacin by Bacteroides fragilis compared with that of five fluoroquinolones
Author(s) -
Vito Ricci
Publication year - 2003
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkg418
Subject(s) - bacteroides fragilis , microbiology and biotechnology , bacteroidaceae , bacteroides , cephalosporin , antibacterial agent , antibiotics , chemistry , biology , bacteria , genetics
Garenoxacin is a novel des-F(6)-quinolone with good anti-anaerobe activity. The accumulation of garenoxacin and five other quinolones in the presence and absence of a variety of efflux pump inhibitors, including carbonyl cyanide m-chlorophenyl hydrazone (CCCP: 100 microM), verapamil (25 microM), reserpine (20 mg/L), sodium orthovanadate (50 microM) and Phe-Arg-beta-naphthylamide (MC-207110) (20 mg/L) was investigated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom